[Federal Register Volume 76, Number 52 (Thursday, March 17, 2011)]
[Notices]
[Page 14690]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-6163]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated November 18, 2010, and published in the Federal
Register on December 3, 2010, (75 FR 75498), Agilent Technologies,
25200 Commercentre Drive, Lake Forest, California 92630-8810, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phencyclidine (7471)........................ II
1-piperidinocyclohexanecarbonitrile (8603).. II
Benzoylecgonine (9180)...................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Agilent Technologies to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Agilent Technologies to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: March 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-6163 Filed 3-16-11; 8:45 am]
BILLING CODE 4410-09-P